Venus Remedies Limited(IN:VENUSREM)
₹1,501.95+58.90 (+4.08%)
IN:VENUSREM
Venus Remedies Limited financials statements
₹1,501.95
At close:+58.90 (+4.08%)
Want to see IN:VENUSREM full AI Analyst Report?
Venus Remedies Limited (VENUSREM) Financial Statements
1 Followers
Venus Remedies Limited Financial Overview
Venus Remedies Limited's market cap is currently ₹20.08B. The company's EPS TTM is ₹91.04; its P/E ratio is 16.45; and it has a dividend yield of 0.67%. Venus Remedies Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 7.70B | ₹ 6.48B | ₹ 5.91B | ₹ 5.56B | ₹ 5.99B |
| Gross Profit | ₹ 2.68B | ₹ 1.66B | ₹ 2.18B | ₹ 2.25B | ₹ 2.00B |
| Operating Income | ₹ 1.22B | ₹ 410.30M | ₹ 331.57M | ₹ 273.20M | ₹ 280.97M |
| EBITDA | ₹ 1.60B | ₹ 944.10M | ₹ 711.80M | ₹ 703.46M | ₹ 701.40M |
| Net Income | ₹ 1.03B | ₹ 453.20M | ₹ 284.91M | ₹ 265.70M | ₹ 407.24M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 1.04B | ₹ 1.64B | ₹ 838.05M | ₹ 720.77M | ₹ 432.56M |
| Total Assets | ₹ 8.54B | ₹ 7.16B | ₹ 6.27B | ₹ 6.01B | ₹ 5.80B |
| Total Debt | ₹ 124.10M | ₹ 16.90M | ₹ 413.25M | ₹ 422.90M | ₹ 428.45M |
| Net Debt | ₹ -182.00M | ₹ -784.10M | ₹ -76.30M | ₹ 210.80M | ₹ -4.11M |
| Total Liabilities | ₹ 1.90B | ₹ 1.55B | ₹ 1.39B | ₹ 1.41B | ₹ 1.39B |
| Stockholders' Equity | ₹ 6.64B | ₹ 5.61B | ₹ 4.88B | ₹ 4.60B | ₹ 4.40B |
| Cash Flow | |||||
| Free Cash Flow | ₹ 1.20B | ₹ 812.90M | ₹ 278.40M | ₹ 288.02M | ₹ 272.94M |
| Operating Cash Flow | ₹ 1.57B | ₹ 909.20M | ₹ 372.85M | ₹ 366.20M | ₹ 410.01M |
| Investing Cash Flow | ₹ -1.84B | ₹ -807.90M | ₹ -72.09M | ₹ -508.30M | ₹ -166.26M |
| Financing Cash Flow | ₹ -25.30M | ₹ -9.50M | ₹ -10.83M | ₹ -5.70M | ₹ -94.77M |
Currency in INR

